Neuroprotective effects of Eriobotrya japonica against β-amyloid-induced oxidative stress and memory impairment

Food and Chemical Toxicology

Volumn 49, Issue 4, 2011, Pages 780-784

  Kim, Mi Jeong ^a   Lee, Jeongmin ^b   Seong, Ah Reum ^a   Lee, Yoo Hyun ^c   Kim, Yung Jae ^d   Baek, Hum Young ^d   Kim, Young Jun ^e   Jun, Woo Jin ^f   Yoon, Ho Geun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

^c Suwon University   (South Korea)

^d Korea INSpharm Research Institute   (South Korea)

^e Korea University   (South Korea)

^f Chonnam National University   (South Korea)

Author keywords

Amyloid; Alzheimer's disease; Cognitive function; Eriobotrya japonica; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; ERIOBOTRYA JAPONICA EXTRACT; NEUROPROTECTIVE AGENT; PLANT EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; HUMAN; HUMAN CELL; LATENT PERIOD; LIPID PEROXIDATION; LOQUAT; MALE; MEMORY DISORDER; MOUSE; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; SPATIAL MEMORY; WORKING MEMORY;

ANIMALS; ERIOBOTRYA; FREE RADICAL SCAVENGERS; MEMORY DISORDERS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PC12 CELLS; RATS;

ERIOBOTRYA JAPONICA; MUS;

EID: 79952439868     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.11.043     Document Type: Article

References (39)

1. Akerboom T., Sies H. Assays of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods in Enzymology 1981, 373-382. Academic Press, New York. L. Parker (Ed.).
2. Alkam T., Nitta A., Miaoguch H., Itoh A., Murai R., Nagai T., Yamada K., Nabeshima T. The extensive nitration of neurofilament light chain in the hippocampus is associated with the cognitive impairment induced by amyloid beta in mice. J. Pharmacol. Exp. Ther. 2008, 327:137-147.
3. Atumi N., Akio I., Takaaki H., Toshitaka N. β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 1994, 170:63-66.
4. Ben-Yoseph O., Boxer P.A., Ross B.D. Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J. Neurochem. 1996, 66:2329-2337.
5. Butterfield D.A., Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential caused and consequences involving amyloid-peptide associated free radical oxidative stress. Free Radic. Biol. Med. 2002, 32:1050-1060.
6. Chen J., Li W.L., Wu J.L., Ren B.R., Zhang H.Q. Hypoglycemic effects of sesquiterpene glycosides isolated from leaves of loquat (Eriobotrya japonica (Thunb.) Lindl.). Phytomedicine 2008, 15:98-102.
7. Choi S.J., Kim M.J., Heo H.J., Kim J.K., Jun W.J., Kim H.K., Kim E.K., Kim M.O., Cho H.Y., Hwang H.J., Kim Y.J., Shin D.H. Ameliorative effect of 1,2-benzenedicarboxylic acid dinoyl ester against amyloid peptide-induced neurotoxicity. Amyloid 2009, 16:15-24.
8. Citron M. Alzheimer disease: treatment in discovery and development. Nat. Neurosci. 2002, 5:1055-1057.
9. Colye J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993, 262:689-695.
10. Foy C.J., Passmor A.P., Vahidassr M.D., Young I.S., Lawson J.T. Plasma chain-breaking antioxidants in Alzheimer's disease, vesculardemetial, and Parkinson's disease. QJMJ 1999, 92:39-45.
11. Fu A.L., Dong Z.H., Sun M.J. Protective effect of N-acetyl-l-cysteine on amyloid β-peptide-induced learning and memory deficits in mice. Brain Res. 2006, 1109:201-206.
12. Halliwell B., Guttridge J.M.C., Vross C.E. Free radicals, antioxidants, and human disease: where are we now?. J. Lab. Clin. Med. 1992, 119:598-620.
13. Jhoo J.H., Kim H.C., Toshitaka N., Kiyofumi Y., Shin E.J., Jhoo W.K., Kim W.K., Kang K.S., Jo S.A., Woo J.I. β-Amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav. Brain Res. 2004, 155:185-196.
14. Joseph J.A., Shukitt-Hale B., Denisova N.A., Bielinski D., Martin A., McEwen J.K., Bikdorf P.C. Reversals of alternated declines in neuronal signal transduction, cognitive, and behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J. Neruosci. 1999, 19:8114-8121.
15. Keller J.N., Mattson M.P. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in nervous system. Rev. Neurosci. 1998, 9:105-116.
16. Kim H.C., Yamamda K., Nitta A., Olariu A., Tran M.H., Mizuno M. Immunocytochemical evidence that amyloid β (1-42) impairs endogenous antioxidant system in vivo. Neuroscience 2003, 119:399-419.
17. Lee M.H., Son Y.K., Han Y.M. Tissue factor inhibitory sesquiterpene glycoside from Eriobotrya japonica. Achr. Phar. Res. 2004, 27:619-623.
18. Li W.L., Wu J.L., Ren B.R., Chen J., Lu C.G. Pharmacological studies on anti-hyperglycemic effect of Folium eriobotryae. AJCM 2007, 35:705-711.
19. Liang Z.Z., Aquino R., Feo V.D., Simon F.D., Pizza C. Polyhydroxylated triterpenes from Eriobotrya japonica. Planta Med. 1990, 56:330-332.
20. Lyras L., Cairns N.J., Jenner A., Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 1997, 68:2061-2069.
21. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 1997, 23:134-147.
22. Markesbery W.R., Carney J.M. Oxidative alternation in Alzheimer's disease. Brain Pathol. 1999, 9:133-146.
23. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 2000, 1:120-129.
24. Mecocci L., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 1994, 36:747-751.
25. Meunier J., Ieni J., Maurice T. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta 25-35 peptide-induced toxicity in mice involved an interaction with the sigma 1 receptor. Br. J. Pharmacol. 2006, 149:998-1012.
26. Mohammad L.E., Ali S. Antioxidant, free radical scavenging activities of Salvia brachyantha and its protective effect against oxidative cardiac cell injury. Food Chem. Toxicol. 2010, 48:846-853.
27. Mohanakumar K.P., de Bartolomeis A., Wu R.M., Yeh K.J., Strnberger L.M., Peng S.Y., Murphy D.L., Chueh C.C. Ferrous-citrate complex and nigral degeneration: evidence for free radical formation and lipid peroxidation. Ann. NY Acad. Sci. 1994, 738:392-399.
28. Nitta A., Itoh A., Hasegawa T., Nebeshima T. Beta-amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 1994, 170:63-66.
29. Oliver C.N., Starke-Reed P.E., Stadtman E.R., Lui G.J., Carnet J.M., Floyd R.A. Oxidative damage to brain proteins, loss of glutamine synthetase activity, production of free radicals during ischemica/reperfusion injury of gerbil brains. Proc. Natl. Acad. Sci. USA 1990, 87:5144-5147.
30. Park S.Y., Kim H.S., Cho E.K., Kwon B.Y., Phark S.H., Hwang K.W., Sul D.G. Curcumin protected PC12 cells against beta-amyloid induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem. Toxicol. 2008, 46:2881-2887.
31. Razienh Y., Hamad S. Protective effect of triazine-derivative (AA3E2) on β-amyloid-induced damage in SK-N-MC cells. Toxicol. in Vitro 2009, 23:1277-1283.
32. Shen Z., Wangn G., Linn S.Z. Two-way shuttle box avoidance conditioning and brain NADH in rats. Physiol. Behav. 1990, 48:515-517.
33. Siesjo S.K., Agardh C.D., Bengtsson F. Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev. 1990, 1:165-211.
34. Tanaka K., Nishizono S., Makino N., Tamaru S., Terai O., Ikeda I. Hypoglicemic activity of Eriobotrya japonica seed in type 2 diabetic rats and mice. Biosci. Biotechnol. Biochem. 2008, 72:686-693.
35. Tran M.H., Yamada K., Olariu A., Mizuno M., Ren X.H., Nabeshima T. Amyloid beta-peptide induced nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitor. FASEB J. 2001, 15:1407-1409.
36. Yamaguchi Y., Kawashima S. Effects of amyloid-β-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat. Eur. J. Pharmacol. 2001, 421:256-272.
37. Yan J.J., Cho J.Y., Kim H.S., Kim K.L., Jung J.S., Huh S.O., Suh H.W., Kim Y.H., Song D.K. Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol. 2001, 133:89-96.
38. Yuan Y.V., Kitts D.D., Godin D.V. Heart and red blood cell antioxidant status and plasma lipid levels in the spontaneously hypertensive and normotensive Wistar-Kyoto rat. J. Physiol. Pharmacol. 1996, 74:290-297.
39. Zheng, L., Kagedal, K., Dehvari, N., Benedikz, E., Cowburn, R., Marcusson, J., Terman, A., 2009. Oxidative stress induced macroautophagy of amyloid beta-protein and ensuing apoptosis. Free Radic. Biol. Med. 246, 422-429.